dr. hurvitz on her2-targeted therapies in breast cancer
Published 6 years ago • 419 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
1:37
dr. hurvitz on how to navigate her2-targeted therapy in breast cancer
-
1:20
dr. hurvitz on the evolution of treatment in metastatic her2 breast cancer
-
1:39
dr. hurvitz on the lack of predictive biomarkers in her2 breast cancer
-
3:20
dr. hurvitz on eliminating anthracyclines in her2 breast cancer treatment
-
1:58
dr. hurvitz discusses role of pertuzumab in her2 breast cancer
-
1:03
dr. hurvitz on steps to take with her2-positive breast cancer research
-
1:11
dr. hurvitz on importance of biosimilars in her2 breast cancer
-
0:59
sequencing her2-targeted therapies in breast cancer
-
1:35
dr. hurvitz on therapeutics for her2 metastatic breast cancer
-
0:58
dr. hurvitz on treatment options for her2-positive breast cancer
-
2:03
dr. hurvitz on novel agents in her2-positive breast cancer
-
5:28
her2-targeted therapy in early breast cancer
-
1:55
dr. hurvitz on novel emerging agents in her2 breast cancer
-
1:29
dr. hurvitz on standards of care in her2 breast cancer
-
3:45
evolving landscape of her2-targeted therapy in breast cancer
-
2:15
dr. hurvitz on neoadjuvant therapy for her2 breast cancer
-
1:27
dr. hurvitz discusses de-escalation in her2 breast cancer
-
7:41
her2-targeted therapy in early stage her2 breast cancer
-
1:26
dr. hurvitz on unmet needs in her2 breast cancer